Tagged policy

The Forces Behind Rising Drug Prices: Looking Past Martin Shkreli and Daraprim

  Turing Pharmaceuticals, led by CEO Martin Shkreli, recently acquired Daraprim, a drug that treats a deadly parasitic infection, and promptly raised its price from $13.50 to $750. Shkreli earned himself the reputation of a “pharma bro” through his brash handling of the situation in the media and especially on Twitter, where he called critics…

Images are for demo purposes only and are properties of their respective owners. Old Paper by ThunderThemes.net